- Tytuł:
- 98 (PB088) - Discovery and validation of biomarkers to support clinical development of NXP800: A first-in-class orally active, small-molecule HSF1 pathway inhibitor
- Autorzy:
- Źródło:
-
In
European Journal of Cancer October 2022 174 Supplement 1:S35-S35
Czasopismo naukowe